Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 530

1.

Journal of Diabetes Science and Technology: A Success Story!

Heinemann L, Grodsky GM, Klonoff DC.

J Diabetes Sci Technol. 2019 Oct 16:1932296819881340. doi: 10.1177/1932296819881340. [Epub ahead of print] No abstract available.

PMID:
31617406
2.

Determination of Postprandial Glycemic Responses by Continuous Glucose Monitoring in a Real-World Setting.

Röhling M, Martin T, Wonnemann M, Kragl M, Klein HH, Heinemann L, Martin S, Kempf K.

Nutrients. 2019 Sep 27;11(10). pii: E2305. doi: 10.3390/nu11102305.

3.

Usage of Hydrocolloid-Based Plasters in Patients Who Have Developed Allergic Contact Dermatitis to Isobornyl Acrylate While Using Continuous Glucose Monitoring Systems.

Kamann S, Heinemann L, Oppel E.

J Diabetes Sci Technol. 2019 Sep 20:1932296819876964. doi: 10.1177/1932296819876964. [Epub ahead of print]

PMID:
31538817
4.

Continuous Glucose Monitoring in People With Type 1 Diabetes on Multiple-Dose Injection Therapy: The Relationship Between Glycemic Control and Hypoglycemia.

Oliver N, Gimenez M, Calhoun P, Cohen N, Moscardo V, Hermanns N, Freckmann G, Reddy M, Heinemann L.

Diabetes Care. 2019 Sep 17. pii: dc190977. doi: 10.2337/dc19-0977. [Epub ahead of print]

5.

The implanted glucose monitoring system Eversense: An alternative for diabetes patients with isobornyl acrylate allergy.

Oppel E, Kamann S, Heinemann L, Reichl FX, Högg C.

Contact Dermatitis. 2019 Aug 28. doi: 10.1111/cod.13392. [Epub ahead of print]

PMID:
31463958
6.

Benefit of Digital Tools Used for Integrated Personalized Diabetes Management: Results From the PDM-ProValue Study Program.

Heinemann L, Schramm W, Koenig H, Moritz A, Vesper I, Weissmann J, Kulzer B.

J Diabetes Sci Technol. 2019 Aug 5:1932296819867686. doi: 10.1177/1932296819867686. [Epub ahead of print]

PMID:
31378074
7.

Evaluation of Isobornyl Acrylate Content in Medical Devices for Diabetes Treatment.

Kamann S, Oppel E, Liu F, Reichl FX, Heinemann L, Högg C.

Diabetes Technol Ther. 2019 Oct;21(10):533-537. doi: 10.1089/dia.2019.0163. Epub 2019 Jul 9.

PMID:
31287728
8.

Benefits and Limitations of MARD as a Performance Parameter for Continuous Glucose Monitoring in the Interstitial Space.

Heinemann L, Schoemaker M, Schmelzeisen-Redecker G, Hinzmann R, Kassab A, Freckmann G, Reiterer F, Del Re L.

J Diabetes Sci Technol. 2019 Jun 19:1932296819855670. doi: 10.1177/1932296819855670. [Epub ahead of print]

PMID:
31216870
9.

Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range.

Battelino T, Danne T, Bergenstal RM, Amiel SA, Beck R, Biester T, Bosi E, Buckingham BA, Cefalu WT, Close KL, Cobelli C, Dassau E, DeVries JH, Donaghue KC, Dovc K, Doyle FJ 3rd, Garg S, Grunberger G, Heller S, Heinemann L, Hirsch IB, Hovorka R, Jia W, Kordonouri O, Kovatchev B, Kowalski A, Laffel L, Levine B, Mayorov A, Mathieu C, Murphy HR, Nimri R, Nørgaard K, Parkin CG, Renard E, Rodbard D, Saboo B, Schatz D, Stoner K, Urakami T, Weinzimer SA, Phillip M.

Diabetes Care. 2019 Aug;42(8):1593-1603. doi: 10.2337/dci19-0028. Epub 2019 Jun 8. Review.

10.

Storage Conditions of Insulin in Domestic Refrigerators and When Carried by Patients: Often Outside Recommended Temperature Range.

Braune K, Kraemer LA, Weinstein J, Zayani A, Heinemann L.

Diabetes Technol Ther. 2019 May;21(5):238-244. doi: 10.1089/dia.2019.0046. Epub 2019 Apr 19.

PMID:
31009254
11.

Evaluating Glucose Control With a Novel Composite Continuous Glucose Monitoring Index.

Leelarathna L, Thabit H, Wilinska ME, Bally L, Mader JK, Pieber TR, Benesch C, Arnolds S, Johnson T, Heinemann L, Hermanns N, Evans ML, Hovorka R.

J Diabetes Sci Technol. 2019 Mar 31:1932296819838525. doi: 10.1177/1932296819838525. [Epub ahead of print]

PMID:
30931606
12.

Comment on Umpierrez and Klonoff. Diabetes Technology Update: Use of Insulin Pumps and Continuous Glucose Monitoring in the Hospital. Diabetes Care 2018;41:1579-1589.

Grammes J, Kuestner E, Heinemann L, Kubiak T.

Diabetes Care. 2019 Apr;42(4):e64-e65. doi: 10.2337/dc18-2455. No abstract available.

PMID:
30894388
13.

Diabetes Technology and Waste: A Complex Problem Piling Up!

Heinemann L, Krisiunas E.

J Diabetes Sci Technol. 2019 Sep;13(5):815-816. doi: 10.1177/1932296819836395. Epub 2019 Mar 13. No abstract available.

PMID:
30866677
14.

Elderly Patients With Diabetes: Special Aspects to Consider.

Heinemann L, Klonoff DC, Kubiak T.

J Diabetes Sci Technol. 2019 Jul;13(4):611-613. doi: 10.1177/1932296819833862. Epub 2019 Mar 10. No abstract available.

PMID:
30854888
15.

Impact of CGM on the Management of Hypoglycemia Problems: Overview and Secondary Analysis of the HypoDE Study.

Hermanns N, Heinemann L, Freckmann G, Waldenmaier D, Ehrmann D.

J Diabetes Sci Technol. 2019 Jul;13(4):636-644. doi: 10.1177/1932296819831695. Epub 2019 Mar 6.

PMID:
30841740
16.

New Insulins, Biosimilars, and Insulin Therapy.

Danne T, Heinemann L, Bolinder J.

Diabetes Technol Ther. 2019 Feb;21(S1):S57-S78. doi: 10.1089/dia.2019.2505. Review. No abstract available.

PMID:
30785319
17.

The Effects and Effect Sizes of Real-Time Continuous Glucose Monitoring on Patient-Reported Outcomes: A Secondary Analysis of the HypoDE Study.

Ehrmann D, Heinemann L, Freckmann G, Waldenmaier D, Faber-Heinemann G, Hermanns N.

Diabetes Technol Ther. 2019 Feb;21(2):86-93. doi: 10.1089/dia.2018.0332. Epub 2019 Jan 7.

PMID:
30615479
18.

Barriers and facilitators to employment for young adults with mental illness: a scoping review.

Gmitroski T, Bradley C, Heinemann L, Liu G, Blanchard P, Beck C, Mathias S, Leon A, Barbic SP.

BMJ Open. 2018 Dec 18;8(12):e024487. doi: 10.1136/bmjopen-2018-024487.

19.

Response to Comment on Bergenstal et al. Glucose Management Indicator (GMI): A New Term for Estimating A1C From Continuous Glucose Monitoring. Diabetes Care 2018;41:2275-2280.

Bergenstal RM, Beck RW, Close KL, Grunberger G, Sacks DB, Kowalski A, Brown AS, Heinemann L, Aleppo G, Ryan DB, Riddlesworth TD, Cefalu WT.

Diabetes Care. 2019 Feb;42(2):e29-e30. doi: 10.2337/dci18-0061. Epub 2018 Dec 17. No abstract available.

PMID:
30559104
20.

Subcutaneous Insulin Administration: Sufficient Progress or Ongoing Need?

Pettis RJ, Muchmore D, Heinemann L.

J Diabetes Sci Technol. 2019 Jan;13(1):3-7. doi: 10.1177/1932296818817011. Epub 2018 Dec 7. No abstract available.

PMID:
30522334
21.

Self-measurement of Blood Glucose and Continuous Glucose Monitoring - Is There Only One Future?

Heinemann L, Stuhr A, Brown A, Freckmann G, Breton MD, Russell S, Heinemann L.

Eur Endocrinol. 2018 Sep;14(2):24-29. doi: 10.17925/EE.2018.14.2.24. Epub 2018 Sep 10. Review.

22.

DiaDigital Apps: Evaluation of Smartphone Apps Using a Quality Rating Methodology for Use by Patients and Diabetologists in Germany.

Kaltheuner M, Drossel D, Heinemann L.

J Diabetes Sci Technol. 2019 Jul;13(4):756-762. doi: 10.1177/1932296818803098. Epub 2018 Sep 28.

23.

Concentrated insulins: History and critical reappraisal.

Heinemann L, Beals JM, Malone J, Anderson J, Jacobson JG, Sinha V, Corrigan SM.

J Diabetes. 2019 Apr;11(4):292-300. doi: 10.1111/1753-0407.12861. Epub 2018 Nov 13. Review.

PMID:
30264527
24.

Artificial Pancreas Systems for People With Type 2 Diabetes: Conception and Design of the European CLOSE Project.

Schliess F, Heise T, Benesch C, Mianowska B, Stegbauer C, Broge B, Gillard P, Binkley G, Crône V, Carlier S, Delval C, Petkov A, Beck JP, Lodwig V, Gurdala M, Szecsenyi J, Rosenmöller M, Cypryk K, Mathieu C, Renard E, Heinemann L.

J Diabetes Sci Technol. 2019 Mar;13(2):261-267. doi: 10.1177/1932296818803588. Epub 2018 Sep 21.

25.

Correction: Higher HbA1c Measurement Quality Standards are Needed for Follow-Up and Diagnosis: Experience and Analyses from Germany.

Heinemann L, Kaiser P, Freckmann G, Grote-Koska D, Kerner W, Landgraf R, Merker L, Müller UA, Müller-Wieland D, Roth J, Spannagl M, Wallaschofski H, Nauck M.

Horm Metab Res. 2018 Oct;50(10):e5. doi: 10.1055/a-0746-4288. Epub 2018 Sep 21. No abstract available.

PMID:
30241106
26.

[Pitfalls in the Diagnosis of Diabetes: Are we too Lax with Laboratory Parameters?]

Landgraf R, Nauck M, Freckmann G, Müller UA, Heinemann L, Kellerer M, Müller-Wieland D.

Dtsch Med Wochenschr. 2018 Oct;143(21):1549-1555. doi: 10.1055/a-0673-2156. Epub 2018 Sep 20. German.

27.

Glucose Management Indicator (GMI): A New Term for Estimating A1C From Continuous Glucose Monitoring.

Bergenstal RM, Beck RW, Close KL, Grunberger G, Sacks DB, Kowalski A, Brown AS, Heinemann L, Aleppo G, Ryan DB, Riddlesworth TD, Cefalu WT.

Diabetes Care. 2018 Nov;41(11):2275-2280. doi: 10.2337/dc18-1581. Epub 2018 Sep 17.

PMID:
30224348
28.

Higher HbA1c Measurement Quality Standards are Needed for Follow-Up and Diagnosis: Experience and Analyses from Germany.

Heinemann L, Kaiser P, Freckmann G, Grote-Koska D, Kerner W, Landgraf R, Merker L, Müller UA, Müller-Wieland D, Roth J, Spannagl M, Wallaschofski H, Nauck M.

Horm Metab Res. 2018 Oct;50(10):728-734. doi: 10.1055/a-0721-2273. Epub 2018 Sep 14. Review. Erratum in: Horm Metab Res. 2018 Oct;50(10):e5.

PMID:
30216941
29.

Integrated personalized diabetes management improves glycemic control in patients with insulin-treated type 2 diabetes: Results of the PDM-ProValue study program.

Kulzer B, Daenschel W, Daenschel I, Schramm W, Messinger D, Weissmann J, Vesper I, Parkin CG, Heinemann L.

Diabetes Res Clin Pract. 2018 Oct;144:200-212. doi: 10.1016/j.diabres.2018.09.002. Epub 2018 Sep 8.

30.

Patch Pumps: Are They All the Same?

Heinemann L, Waldenmaier D, Kulzer B, Ziegler R, Ginsberg B, Freckmann G.

J Diabetes Sci Technol. 2019 Jan;13(1):34-40. doi: 10.1177/1932296818795150. Epub 2018 Aug 22.

31.

Open Source Closed-Loop Insulin Delivery Systems: A Clash of Cultures or Merging of Diverse Approaches?

Barnard KD, Ziegler R, Klonoff DC, Braune K, Petersen B, Rendschmidt T, Finan D, Kowalski A, Heinemann L.

J Diabetes Sci Technol. 2018 Nov;12(6):1223-1226. doi: 10.1177/1932296818792577. Epub 2018 Aug 6.

32.

Modeling of Diabetes and Its Clinical Impact.

Fritzen K, Heinemann L, Schnell O.

J Diabetes Sci Technol. 2018 Sep;12(5):976-984. doi: 10.1177/1932296818785642. Epub 2018 Jul 13. Review.

33.

Practical Recommendations for Glucose Measurement, Glucose Monitoring and Glucose Control in Patients with Type 1 or Type 2 Diabetes in Germany.

Heinemann L, Deiss D, Siegmund T, Schlüter S, Naudorf M, von Sengbusch S, Lange K, Freckmann G.

Exp Clin Endocrinol Diabetes. 2018 Jul;126(7):411-428. doi: 10.1055/a-0586-5302. Epub 2018 Jul 5. No abstract available.

PMID:
29975980
34.

Definition, Classification and Diagnosis of Diabetes Mellitus.

Petersmann A, Nauck M, Müller-Wieland D, Kerner W, Müller UA, Landgraf R, Freckmann G, Heinemann L.

Exp Clin Endocrinol Diabetes. 2018 Jul;126(7):406-410. doi: 10.1055/a-0584-6223. Epub 2018 Jul 5.

PMID:
29975979
35.

Real-Time Continuous Glucose Monitoring Usage in Pilots with Diabetes: An Option to Improve Safety.

Jendle J, Heinemann L.

Diabetes Technol Ther. 2018 Jul;20(7):453-454. doi: 10.1089/dia.2018.0099. No abstract available.

PMID:
29958024
36.

Lipohypertrophic Skin Changes in Patients With Diabetes: Visualization by Infrared Images.

Kaltheuner L, Kaltheuner M, Heinemann L.

J Diabetes Sci Technol. 2018 Nov;12(6):1152-1158. doi: 10.1177/1932296818777264. Epub 2018 Jun 1.

37.
38.

Limits to the Evaluation of the Accuracy of Continuous Glucose Monitoring Systems by Clinical Trials.

Schrangl P, Reiterer F, Heinemann L, Freckmann G, Del Re L.

Biosensors (Basel). 2018 May 18;8(2). pii: E50. doi: 10.3390/bios8020050.

39.

Rethinking the Viability and Utility of Inhaled Insulin in Clinical Practice.

Heinemann L, Parkin CG.

J Diabetes Res. 2018 Mar 7;2018:4568903. doi: 10.1155/2018/4568903. eCollection 2018. Review.

40.

Response to "Discrepancies Between Blood Glucose and Interstitial Glucose-Technological Artifacts or Physiology: A Reply".

Siegmund T, Heinemann L, Kolassa R, Thomas A.

J Diabetes Sci Technol. 2018 Jul;12(4):900-902. doi: 10.1177/1932296818770705. Epub 2018 Apr 18. No abstract available.

41.

Continuous Glucose Monitoring (CGM) or Blood Glucose Monitoring (BGM): Interactions and Implications.

Heinemann L.

J Diabetes Sci Technol. 2018 Jul;12(4):873-879. doi: 10.1177/1932296818768834. Epub 2018 Apr 12.

42.

Further Evidence of Severe Allergic Contact Dermatitis From Isobornyl Acrylate While Using a Continuous Glucose Monitoring System.

Kamann S, Aerts O, Heinemann L.

J Diabetes Sci Technol. 2018 May;12(3):630-633. doi: 10.1177/1932296818762946. Epub 2018 Mar 15.

43.

Real-time continuous glucose monitoring in adults with type 1 diabetes and impaired hypoglycaemia awareness or severe hypoglycaemia treated with multiple daily insulin injections (HypoDE): a multicentre, randomised controlled trial.

Heinemann L, Freckmann G, Ehrmann D, Faber-Heinemann G, Guerra S, Waldenmaier D, Hermanns N.

Lancet. 2018 Apr 7;391(10128):1367-1377. doi: 10.1016/S0140-6736(18)30297-6. Epub 2018 Feb 16.

PMID:
29459019
44.

New Insulins, Biosimilars, and Insulin Therapy.

Danne T, Heinemann L, Bolinder J.

Diabetes Technol Ther. 2018 Feb;20(S1):S55-S70. doi: 10.1089/dia.2018.2505. Review. No abstract available.

PMID:
29437477
45.

Blood Glucose Monitoring Data Should Be Reported in Detail When Studies About Efficacy of Continuous Glucose Monitoring Systems Are Published.

Pleus S, Heinemann L, Freckmann G.

J Diabetes Sci Technol. 2018 Sep;12(5):1061-1063. doi: 10.1177/1932296817753629. Epub 2018 Jan 11.

46.

Insulin Concentration in Vials Randomly Purchased in Pharmacies in the United States: Considerable Loss in the Cold Supply Chain.

Carter AW, Heinemann L.

J Diabetes Sci Technol. 2018 Jul;12(4):839-841. doi: 10.1177/1932296817747292. Epub 2017 Dec 21.

47.

Inhaled Insulin: Dead Horse or Rising Phoenix?

Heinemann L.

J Diabetes Sci Technol. 2018 Mar;12(2):239-242. doi: 10.1177/1932296817748231. Epub 2017 Dec 13. No abstract available.

48.

International Consensus on Use of Continuous Glucose Monitoring.

Danne T, Nimri R, Battelino T, Bergenstal RM, Close KL, DeVries JH, Garg S, Heinemann L, Hirsch I, Amiel SA, Beck R, Bosi E, Buckingham B, Cobelli C, Dassau E, Doyle FJ 3rd, Heller S, Hovorka R, Jia W, Jones T, Kordonouri O, Kovatchev B, Kowalski A, Laffel L, Maahs D, Murphy HR, Nørgaard K, Parkin CG, Renard E, Saboo B, Scharf M, Tamborlane WV, Weinzimer SA, Phillip M.

Diabetes Care. 2017 Dec;40(12):1631-1640. doi: 10.2337/dc17-1600. Review.

49.

Improving the Clinical Value and Utility of CGM Systems: Issues and Recommendations: A Joint Statement of the European Association for the Study of Diabetes and the American Diabetes Association Diabetes Technology Working Group.

Petrie JR, Peters AL, Bergenstal RM, Holl RW, Fleming GA, Heinemann L.

Diabetes Care. 2017 Dec;40(12):1614-1621. doi: 10.2337/dci17-0043. Epub 2017 Oct 25. Review.

PMID:
29070577
50.

Improving the clinical value and utility of CGM systems: issues and recommendations : A joint statement of the European Association for the Study of Diabetes and the American Diabetes Association Diabetes Technology Working Group.

Petrie JR, Peters AL, Bergenstal RM, Holl RW, Fleming GA, Heinemann L.

Diabetologia. 2017 Dec;60(12):2319-2328. doi: 10.1007/s00125-017-4463-4. Epub 2017 Oct 25. Review.

PMID:
29067486

Supplemental Content

Loading ...
Support Center